Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Malignant Lymphoma

  Free Subscription


19.11.2018

4 Br J Haematol
1 J Virol
1 Leuk Lymphoma


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Br J Haematol

  1. ADAMS HJA, Kwee TC
    Interim FDG-PET does not predict outcome in advanced-stage Hodgkin lymphoma patients treated with BEACOPP.
    Br J Haematol. 2018 Nov 14. doi: 10.1111/bjh.15602.
    PubMed     Text format    

  2. GALATI D, Zanotta S, Corazzelli G, Bruzzese D, et al
    Circulating dendritic cells deficiencies as a new biomarker in classical Hodgkin lymphoma.
    Br J Haematol. 2018 Nov 13. doi: 10.1111/bjh.15676.
    PubMed     Text format     Abstract available

  3. CIRILLO M, Reinke S, Klapper W, Borchmann S, et al
    The translational science of hodgkin lymphoma.
    Br J Haematol. 2018 Nov 12. doi: 10.1111/bjh.15658.
    PubMed     Text format     Abstract available

  4. MITSUI T, Yokohama A, Koiso H, Saito A, et al
    Prognostic impact of trisomy 21 in follicular lymphoma.
    Br J Haematol. 2018 Nov 12. doi: 10.1111/bjh.15664.
    PubMed     Text format     Abstract available


    J Virol

  5. AYOUBIAN H, Ludwig N, Fehlmann T, Menegatti J, et al
    Infection of cell lines derived from diffuse large B-cell lymphoma (DLBCL) with the Epstein-Barr virus (EBV) alters the miRNA loading of the Ago2-complex.
    J Virol. 2018 Nov 14. pii: JVI.01297-18. doi: 10.1128/JVI.01297.
    PubMed     Text format     Abstract available


    Leuk Lymphoma

  6. CHATURVEDI NK, Hatch ND, Sutton GL, Kling M, et al
    A novel approach to eliminate therapy-resistant mantle cell lymphoma: synergistic effects of Vorinostat with Palbociclib.
    Leuk Lymphoma. 2018 Nov 14:1-10. doi: 10.1080/10428194.2018.1520986.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Malignant Lymphoma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: